Related Experiment Video
Updated: Mar 22, 2026
04:41
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
Published on: March 10, 2023
1.8K
Laparoscopic repeat liver resection for recurrent hepatocellular carcinoma
Brian K P Goh1,2, Jin-Yao Teo1, Chung-Yip Chan1
1Department of Hepatopancreatobiliary and Transplantation Surgery, Singapore General Hospital, Singapore.
ANZ Journal of Surgery
|April 28, 2016
Summary
Laparoscopic repeat liver resection (LRLR) is a safe and feasible option for recurrent hepatocellular carcinoma (rHCC). This minimally invasive approach offers good outcomes even in complex cases with prior surgeries.
Area of Science:
- Hepatobiliary surgery
- Minimally invasive surgery
- Oncology
Background:
- Recurrent hepatocellular carcinoma (rHCC) poses a significant clinical challenge.
- Repeat liver resection is an established treatment for rHCC.
- Laparoscopic techniques are increasingly explored for complex liver procedures.
Purpose of the Study:
- To evaluate the outcomes of laparoscopic repeat liver resection (LRLR) for recurrent hepatocellular carcinoma (rHCC).
- To assess the feasibility and safety of LRLR in patients with prior liver resections and challenging tumor locations.
Main Methods:
- Retrospective review of eight consecutive patients undergoing LRLR for rHCC.
- Analysis of patient history, including previous open or laparoscopic liver resections.
- Evaluation of perioperative outcomes, tumor characteristics, and follow-up data.
Main Results:
- All eight patients achieved R0 resection, indicating complete tumor removal.
- Median follow-up was 7.5 months, with all patients remaining disease-free.
- One conversion to open surgery and one post-operative morbidity were recorded (12.5% each).
- LRLR was performed for tumors in difficult posterosuperior segments in 62.5% of patients.
Conclusions:
- Laparoscopic repeat liver resection (LRLR) is a feasible and safe treatment for recurrent hepatocellular carcinoma (rHCC).
- LRLR can be successfully applied in highly selected patients, including those with prior open resections, cirrhosis, or ipsilateral lobe recurrence.
- This approach demonstrates potential for excellent oncological outcomes in challenging rHCC cases.
